Overweight and Obesity Clinical Trial
— SWOPOfficial title:
Daily Self-Weighing for Obesity Management in Primary Care
Verified date | November 2023 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Many adults with obesity continue to gain weight even though they do not want to. This project will test the effects of a primary care intervention in which people with obesity receive an electronic scale and recommendations to weigh themselves daily. This will help us understand whether daily self-weighing might be a way to prevent continued weight gain.
Status | Active, not recruiting |
Enrollment | 396 |
Est. completion date | March 2025 |
Est. primary completion date | March 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age 19-65 years - Body mass index (BMI) 30 - 50 kg/m2 - Receives care at one of the participating primary care clinics - Resides in one location at least 5 days each week - Possesses a smartphone with data plan - Wi-Fi or Bluetooth internet connection in home Exclusion Criteria: - Pregnancy or anticipating pregnancy during study duration. This is a weight loss study and weight gain/loss due to pregnancy and/or delivery would confound study results. Additionally, weight loss is not recommended for pregnant women. - Unwilling or unable to do any of the following: give informed consent, accept random assignment, attend five measurement assessments - Likely to relocate and no longer be seen at UAB primary care in the next 2 years - Weight loss =5% of body weight in past 6 months (other than postpartum) - Weight >180 kg (396lbs) due to the limitation of the scale being used. - Current participation in another weight loss study - Bariatric surgery or revision in the past two years - Prescription weight loss medications within the past 6 months - Another household member already participating in the study - Potential participants living farther than 50 miles driving distance from UAB will be excluded from the study. It is expected that those living farther away will be more difficult to retain as study participants. |
Country | Name | City | State |
---|---|---|---|
United States | University of Alabama at Birmingham | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham | Cornell University, Indiana University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Mean self-efficacy score assessed by the Self-Efficacy for Weight Loss Trials Scale at month 12 | Self-efficacy (i.e., confidence in one's ability to execute the behaviors required to meet a goal) for healthy eating, physical activity, and weight loss will be assessed with the 12-item Self-Efficacy for Weight Loss Trials Scale | month 12 | |
Other | Mean self-efficacy score assessed by the Self-Efficacy for Weight Loss Trials Scale at month 24 | Self-efficacy (i.e., confidence in one's ability to execute the behaviors required to meet a goal) for healthy eating, physical activity, and weight loss will be assessed with the 12-item Self-Efficacy for Weight Loss Trials Scale | month 24 | |
Other | Mean score on the Eating Disorder Diagnostic Screening form at month 12 | The 22-item Eating Disorder Diagnostic Screening will monitor symptoms of eating disorders | month 12 | |
Other | Mean score on the Eating Disorder Diagnostic Screening form at month 24 | The 22-item Eating Disorder Diagnostic Screening will monitor symptoms of eating disorders | month 24 | |
Other | Mean score on the Body Shape Questionnaire-16A at month 12 | The 16-item Body Shape Questionnaire-16A will monitor symptoms of body image disturbance | month 12 | |
Other | Mean score on the Body Shape Questionnaire-16A at month 24 | The 16-item Body Shape Questionnaire-16A will monitor symptoms of body image disturbance | month 24 | |
Other | Mean score on the Patient Health Questionnaire-8 (PHQ-8) at month 12 | The Patient Health Questionnaire-8 (PHQ-8) will monitor depressive symptoms | month 12 | |
Other | Mean score on the Patient Health Questionnaire-8 (PHQ-8) at month 24 | The Patient Health Questionnaire-8 (PHQ-8) will monitor depressive symptoms | month 24 | |
Other | Healthcare utilization at month 12 assessed by the EuroQOL (EQ-5D-5L) | Self-reported use of health care services (hospitalizations, ER/physician office visits, prescription drugs, etc.) and associated costs will be collected using the EuroQOL (EQ-5D-5L) | baseline to month 12 | |
Other | Healthcare utilization at month 24 assessed by the EuroQOL (EQ-5D-5L) | Self-reported use of health care services (hospitalizations, ER/physician office visits, prescription drugs, etc.) and associated costs will be collected using the EuroQOL (EQ-5D-5L) | month 12 to month 24 | |
Primary | Change in body weight from baseline to month 6 | Body weight measured to the nearest 0.1 kg using a calibrated electronic scale | 6 months | |
Primary | Change in body weight from baseline to month 12 | Body weight measured to the nearest 0.1 kg using a calibrated electronic scale | 12 months | |
Primary | Change in body weight from baseline to month 18 | Body weight measured to the nearest 0.1 kg using a calibrated electronic scale | 18 months | |
Primary | Change in body weight from baseline to month 24 | Body weight measured to the nearest 0.1 kg using a calibrated electronic scale | 24 months | |
Secondary | Average number of weight control behaviors endorsed on the Weight Control Practices Survey at month 6 | A modified version of the 23-item Weight Control Practices Survey will assess a variety of strategies for weight control, including participation in structured programs and/or self-directed weight control behaviors (e.g., reducing fat intake, maintaining food records, increasing physical activity, frequency of self-weighing). The survey measures presence and duration (in weeks) of each behavior. | baseline to month 6 | |
Secondary | Average number of weight control behaviors endorsed on the Weight Control Practices Survey at month 12 | A modified version of the 23-item Weight Control Practices Survey will assess a variety of strategies for weight control, including participation in structured programs and/or self-directed weight control behaviors (e.g., reducing fat intake, maintaining food records, increasing physical activity, frequency of self-weighing). The survey measures presence and duration (in weeks) of each behavior. | month 6 to month 12 | |
Secondary | Average number of weight control behaviors endorsed on the Weight Control Practices Survey at month 18 | A modified version of the 23-item Weight Control Practices Survey will assess a variety of strategies for weight control, including participation in structured programs and/or self-directed weight control behaviors (e.g., reducing fat intake, maintaining food records, increasing physical activity, frequency of self-weighing). The survey measures presence and duration (in weeks) of each behavior. | month 12 to month 18 | |
Secondary | Average number of weight control behaviors endorsed on the Weight Control Practices Survey at month 24 | A modified version of the 23-item Weight Control Practices Survey will assess a variety of strategies for weight control, including participation in structured programs and/or self-directed weight control behaviors (e.g., reducing fat intake, maintaining food records, increasing physical activity, frequency of self-weighing). The survey measures presence and duration (in weeks) of each behavior. | month 18 to month 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03994419 -
PErioperAtive CHildhood ObesitY
|
||
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03602001 -
Attentive Eating for Weight Loss
|
N/A | |
Recruiting |
NCT06269159 -
The Power of 24-hour: Co-designing Intervention Components
|
||
Completed |
NCT03377244 -
Healthy Body Healthy Souls in the Marshallese Population
|
N/A | |
Completed |
NCT02996864 -
Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II
|
N/A | |
Completed |
NCT04647149 -
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
|
N/A | |
Terminated |
NCT03914066 -
A Group-based Treatment of Overweight and Obesity in Primary Care
|
N/A | |
Completed |
NCT03685656 -
Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers
|
N/A | |
Completed |
NCT05051579 -
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
|
Phase 2 | |
Completed |
NCT04611477 -
Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals
|
N/A | |
Active, not recruiting |
NCT05330247 -
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
|
N/A | |
Completed |
NCT03599115 -
Effects of Inhibitory Control Training in Eating Behaviors
|
N/A | |
Recruiting |
NCT06094231 -
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
|
N/A | |
Recruiting |
NCT05938894 -
Train Your Brain - Executive Function
|
N/A | |
Recruiting |
NCT05987306 -
A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Completed |
NCT05055362 -
Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study
|
N/A | |
Completed |
NCT04520256 -
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
|
Phase 2/Phase 3 | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A |